Responsibilities & Role

The bche is counseled by an academic advisory board. The Advisory Board accompanies the research activities of the bche and provides suggestions for the further academic development of the center. It also advises the bche with regard to the funding of dialogue between the members of the bche and healthcare organizations.
The Advisory Board is made up of respected scientists in the field of health economics as well as high-ranking internships from healthcare organizations. The Advisory Board also includes one professor from each of the three sponsoring faculties.
The members of the Advisory Board are nominated by the Faculty Assemblies or the relevant boards of the participating institutions at the suggestion of the Board of Directors and elected by the Faculty Assembly of Business and Economics for a period of three years. Re-election is possible.

Members

Interpharma

René P. Buholzer

René P. Buholzer, Dr.rer.publ.HSG, has been CEO and Delegate of the Board of Directors of Interpharma, the association of research-based pharmaceutical companies in Switzerland, since 2017. Before joining Interpharma, he was Global Head of Public Policy and Sustainability at Credit Suisse for more than 10 years. Dr. Buholzer obtained a doctorate from the University of St. Gallen, where he also worked as a lecturer for 18 years. He is the author of three books and has published widely in the areas of public policy, economic policy and Swiss-EU relations.

Department of Public Health

Sabina M. De Geest

Sabina M. De Geest is Professor of Nursing Science at the Department of Public Health of the Medical Faculty of the University of Basel. She also holds adjunct appointments at the KU Leuven in Belgium, Johns Hopkins University, the University of Pittsburgh and New York University in the USA. She leads the international PIONEER group, an interdisciplinary research team focusing on behavioral (e.g. medication adherence) and psychosocial issues in chronically ill patients (e.g. transplantation, rheumatology and the elderly). She is a co-founder of the Swiss Implementation Science Network (IMPACT).

FMH

Yvonne Gilli

Yvonne Gilli, Dr. med., has been President of the Swiss Medical Association (FMH) since February 1, 2021. Yvonne Gilli completed three years of training as a nurse. She then went on to complete her Maturität on the second educational path and then studied medicine. Since 1996, she has been working in her own practice as a specialist in gynecology and also offers complementary medicine. From 2004 to 2007, she was a member of the cantonal council in St. Gallen and a member of the National Council from the elections on October 21, 2007 until the Swiss parliamentary elections in 2015.

F. Hoffmann-La Roche AG

Ansgar Hebborn

Ansgar Hebborn holds a doctorate in economics and has been Global Policy Leader at F. Hoffmann-La Roche AG in Basel, Switzerland, since 2021. In this capacity, he represents the company in international industry associations and expert committees related to HTA, reimbursement and pricing of innovative healthcare technologies. He heads the HTA working group of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Previously, as Managing Director of the Research Center for Social Law and Health Economics at the University of Bayreuth, he dealt in particular with issues relating to the reimbursement of service providers in the SHI system.

santésuisse

Christoph Kilchenmann

Christoph Kilchenmann has been Head of the Fundamentals department at santésuisse since October 1, 2017. After studies in macroeconomics at the University of Bern, he obtained a doctorate at the University of Basel. At the Federal Office of Public Health (FOPH), Kilchenmann first headed the Statistics and Mathematics Section and then the Premiums and Solvency Supervision Section until he joined santésuisse.

Federal Office of Public Health FOPH

Anne Lévy

Anne Lévy, lic. sc. pol., has been Director of the Federal Office of Public Health FOPH since 2020. Lévy was previously CEO of the University Psychiatric Clinics in Basel (UPK) and was Head of Health Protection at the Canton of Basel-Stadt Department of Health between 2009 and 2015. In addition to her degree in political science, she holds an Executive MBA from the University of Fribourg.

Department of Pharmaceutical Sciences

Christoph R. Meier

Christoph R. Meier is Professor of Clinical Pharmacy & Epidemiology at the University of Basel. He obtained a doctorate at the University Hospital Basel and subsequently worked at the University Hospital Zurich. in 1995, he completed a postdoctoral fellowship at the Boston Collaborative Drug Surveillance Center in the USA, during which time he obtained a Master's degree in Epidemiology at Harvard. He was awarded a titular professorship in 2008 and was appointed Head of Hospital Pharmacy and Professor of Clinical Pharmacy and Pharmacoepidemiology at the University of Basel in 2009, where he has been Head of Department since 2012.

Faculty of Business and Economics

Alois Stutzer

Alois Stutzer has been Professor of Political Economy at the Faculty of Business and Economics at the University of Basel since 2009. He studied economics at the University of Zurich and obtained a doctorate in this subject in 2001. In 2002, he was a visiting researcher at the Center for Law and Economics at the University of California in Berkeley. From 2003 to July 2006, he worked as a senior resident at the Institute for Empirical Economic Research at the University of Zurich. He then accepted an appointment as Assistant Professor of Public Economics/Public Finance at the University of Basel.

Ludwig-Maximilians-University Munich

Joachim Winter

Joachim Winter is Professor of Macroeconomics and Empirical Economic Research at the Ludwig Maximilian University of Munich. He studied economics at the University of Augsburg and the London School of Economics from 1987 to 1993. He obtained a doctorate in 1997 under Axel Börsch-Supan at the University of Mannheim. his habilitation followed in 2002. He was then Deputy Director of the Mannheim Research Institute for Economics and Demographic Change until 2004. in 2004, he accepted an appointment at the Ludwig Maximilian University of Munich.

To top